The use of exogenous phosphocreatine in surgical correction of valvular heart defects under cardiopulmonary bypass: a randomized, double-blind, placebo-controlled pilot studyVladimir Boboshko, A. М. Chernyavskiy, В Н Ломиворотов et al.|Patologiya krovoobrashcheniya i kardiokhirurgiya|2025Cited by 0